Dolecek T A, Propp J M, Stroup N E,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009[J]. Neuro Oncol, 2012, 14(Suppl 5): v1-v49. [2]Komotar R J, Otten M L, Moise G,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review[J]. Clin Med Oncol, 2008, 2: 421-422. [3]Ehlers R A, Kim S H, Zhang Y,et al. Gut peptide receptor expression in human pancreatic cancers [J]. Ann Surg, 2000, 231(6): 838-848. [4]Zhao W J, Zhang W, Li G L,et al. Differential expression of MMP-9 and AQP4 in human glioma samples[J]. Folia Neuropathol, 2012, 50(2): 176-186. [5]Sun C, Wang Q, Zhou H,et al. Antisense MMP-9 RNA inhibits malignant glioma cell growth ？in vitro？ and in vivo[J]. Neurosci Bull, 2013, 29(1): 83-93. [6]Souaze F, Dupouy S, Viardot-Foucault V,et al. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression[J]. Cancer Res, 2006, 66(12): 6243-6249. [7]Kim J, Lee J W, Kim S I,et al. Thrombin-induced Migration and Matrix Metalloproteinase-9 Expression Are Regulated by MAPK and PI3K Pathways in C6 Glioma Cells [J]. Korean J Physiol Pharmacol, 2011, 15(4): 211-216. [8]Dupouy S, Mourra N, Doan V K,et al. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers [J]. Biochimie, 2011, 93(9) : 1369-1378. [9]Asano K, Duntsch C D, Zhou Q,et al. Correlation of N-cadherin expression in high grade gliomas with tissue invasion[J]. J Neurooncol, 2004, 70(1): 3-15. [10]Maret D, Gruzglin E, Sadr M S,et al. Surface expression of precursor N-cadherin promotes tumor cell invasion[J]. Neoplasia, 2010, 12(12): 1066-1080. [11]Camand E, Peglion F, Osmani N,et al. N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration[J]. J Cell Sci, 2012, 125(Pt 4): 844-857. [12]Peglion F, Etienne-Manneville S. N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors[J]. Cell Adh Migr, 2012, 6(4): 327-332. [13]Wu W, Tian Y, Wan H,et al. Expression of beta-catenin and E- and N-cadherin in human brainstem gliomas and clinicopathological correlations [J]. Int J Neurosci, 2013, 123(5): 318-323.
